Wu-Wong JR - Search Results

1

Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption.

Chiao JW, Moonga BS, Yang YM, Kancherla R, Mittelman A, Wu-Wong JR, Ahmed T. Chiao JW, et al. Br J Cancer. 2000 Aug;83(3):360-5. doi: 10.1054/bjoc.2000.1261. Br J Cancer. 2000. PMID: 10917552 Free PMC article.

2

Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.

Bagnato A, Salani D, Di Castro V, Wu-Wong JR, Tecce R, Nicotra MR, Venuti A, Natali PG. Bagnato A, et al. Cancer Res. 1999 Feb 1;59(3):720-7. Cancer Res. 1999. PMID: 9973223

3

A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.

Yin JJ, Mohammad KS, Käkönen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM, Guise TA. Yin JJ, et al. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10954-9. doi: 10.1073/pnas.1830978100. Epub 2003 Aug 26. Proc Natl Acad Sci U S A. 2003. PMID: 12941866 Free PMC article.

4

Differential effects of Vitamin D analogs on bone formation and resorption.

Nakane M, Fey TA, Dixon DB, Ma J, Brune ME, Li YC, Wu-Wong JR. Nakane M, et al. J Steroid Biochem Mol Biol. 2006 Jan;98(1):72-7. doi: 10.1016/j.jsbmb.2005.07.007. Epub 2005 Oct 20. J Steroid Biochem Mol Biol. 2006. PMID: 16242929

5

New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade.

Nelson JB, Nguyen SH, Wu-Wong JR, Opgenorth TJ, Dixon DB, Chung LW, Inoue N. Nelson JB, et al. Urology. 1999 May;53(5):1063-9. doi: 10.1016/s0090-4295(98)00658-x. Urology. 1999. PMID: 10223507 Free article.

6

Expression of VDR and CYP24A1 mRNA in human tumors.

Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. Anderson MG, et al. Cancer Chemother Pharmacol. 2006 Jan;57(2):234-40. doi: 10.1007/s00280-005-0059-7. Epub 2005 Sep 23. Cancer Chemother Pharmacol. 2006. PMID: 16180015

7

Effect of castration on endothelin receptors.

Padley RJ, Dixon DB, Wu-Wong JR. Padley RJ, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:442S-445S. doi: 10.1042/CS103S442S. Clin Sci (Lond). 2002. PMID: 12193141

8

Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level.

Opgenorth TJ, Wessale JL, Dixon DB, Adler AL, Calzadilla SV, Padley RJ, Wu-Wong JR. Opgenorth TJ, et al. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S292-6. doi: 10.1097/00005344-200036051-00086. J Cardiovasc Pharmacol. 2000. PMID: 11078402

9

'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects.

Chiou WJ, Wessale JL, von Geldern T, Opgenorth TJ, Wu-Wong JR. Chiou WJ, et al. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S48-52. doi: 10.1097/00005344-200036051-00017. J Cardiovasc Pharmacol. 2000. PMID: 11078333

10

Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.

Wu-Wong JR, Chen YW, Wessale JL. Wu-Wong JR, et al. Am J Physiol Renal Physiol. 2015 Feb 15;308(4):F309-19. doi: 10.1152/ajprenal.00129.2014. Epub 2014 Dec 10. Am J Physiol Renal Physiol. 2015. PMID: 25503724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page